The Role of Parkin-Mediated Mitophagy in Cardiovascular Diseases

The Role of Parkin-Mediated Mitophagy in Cardiovascular Diseases

Loading document ...
Page
of
Loading page ...

Author(s)

Author(s): Xiao Dandan, Zhang Liwei, Wang Jianxun

Download Full PDF Read Complete Article

DOI: 10.18483/ijSci.2049 22 88 25-29 Volume 8 - May 2019

Abstract

Parkin is a protein encoded by the PARK2 gene, whose mutations were first found in patients with Parkinson's disease. Recent studies reveal that Parkin plays an important role in the development of cardiovascular diseases (CVD) in addition to its contribution in neurological and malignant diseases. The abnormalities of mitochondrial functions and structures play crucial role in the development of many pathological disorders, including CVD. Parkin is a vital component of mitophagy process, in which the damaged mitochondria is selectively removed to maintain the cellular homeostasis. This article summarizes the latest current updates of researches related to Parkin-mediated mitophagy and its functions in CVD. This would improve our understanding about the development of CVD and provide new therapeutic targets for the treatment of CVD.

Keywords

Parkin, Mitophagy, Cardiovascular Disease

References

  1. Kitada, T., et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998. 392(6676): p. 605-8.Bjerre, D., et al., Porcine Parkin: molecular cloning of PARK2 cDNA, expression analysis, and identification of a splicing variant. Biochem Biophys Res Commun, 2006. 347(3): p. 803-13.
  2. Hattori, N. and Y. Mizuno, Pathogenetic mechanisms of parkin in Parkinson's disease. Lancet, 2004. 364(9435): p. 722-4.
  3. Narendra, D., et al., Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol, 2008. 183(5): p. 795-803.
  4. Exner, N., et al., Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. Embo j, 2012. 31(14): p. 3038-62.
  5. Corti, O., S. Lesage, and A. Brice, What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev, 2011. 91(4): p. 1161-218.
  6. Kubo, S.I., et al., Parkin is associated with cellular vesicles. J Neurochem, 2001. 78(1): p. 42-54.
  7. Shimura, H., et al., Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol, 1999. 45(5): p. 668-72.
  8. Darios, F., et al., Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum Mol Genet, 2003. 12(5): p. 517-26.
  9. Imai, Y., et al., An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 2001. 105(7): p. 891-902.
  10. Imai, Y., et al., An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 2001. 105(7): p. 891-902.
  11. Shimura, H., et al., Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science, 2001. 293(5528): p. 263-9.
  12. Zhang, Y., et al., Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A, 2000. 97(24): p. 13354-9.
  13. Yorimitsu, T. and D.J. Klionsky, Autophagy: molecular machinery for self-eating. Cell Death Differ, 2005. 12 Suppl 2: p. 1542-52.
  14. Noda, N.N., Y. Ohsumi, and F. Inagaki, Atg8-family interacting motif crucial for selective autophagy. FEBS Lett, 2010. 584(7): p. 1379-85.
  15. De Duve, C. and R. Wattiaux, Functions of lysosomes. Annu Rev Physiol, 1966. 28: p. 435-92
  16. Mouton-Liger, F., et al., PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease. Front Mol Neurosci, 2017. 10: p. 120.
  17. Youle, R.J. and D.P. Narendra, Mechanisms of mitophagy. Nat Rev Mol Cell Biol, 2011. 12(1): p. 9-14.
  18. Jin, S.M. and R.J. Youle, PINK1- and Parkin-mediated mitophagy at a glance. J Cell Sci, 2012. 125(Pt 4): p. 795-9.
  19. Deas, E., et al., PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet, 2011. 20(5): p. 867-79.
  20. Dorn, G.W., 2nd, Central Parkin: The evolving role of Parkin in the heart. Biochim Biophys Acta, 2016. 1857(8): p. 1307-1312.
  21. Chakrama, F.Z., et al., GABARAPL1 (GEC1) associates with autophagic vesicles. Autophagy, 2010. 6(4): p. 495-505.
  22. Lee, Y., et al., Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol Heart Circ Physiol, 2011. 301(5): p. H1924-31.
  23. Hamacher-Brady, A. and N.R. Brady, Mitophagy programs: mechanisms and physiological implications of mitochondrial targeting by autophagy. Cell Mol Life Sci, 2016. 73(4): p. 775-95.
  24. Ding, W.X., et al., Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and Parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem, 2010. 285(36): p. 27879-90.
  25. Zhang, Y., et al., Parkin functions as an E2-dependent ubiquitin– protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A, 2000. 97(24): p. 13354-9.
  26. Chaugule, V.K., et al., Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J, 2011. 30(14): p. 2853-67.
  27. Meng, F., et al., Oxidation of the cysteine-rich regions of parkin perturbs its E3 ligase activity and contributes to protein aggregation. Mol Neurodegener, 2011. 6: p. 34.
  28. Gu, Z., T. Nakamura, and S.A. Lipton, Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol Neurobiol, 2010. 41(2-3): p. 55-72.
  29. Tsang, A.H., et al., S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease. Proc Natl Acad Sci U S A, 2009. 106(12): p. 4900-5.
  30. Hristova, V.A., et al., Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J Biol Chem, 2009. 284(22): p. 14978-86.
  31. Ozawa, K., et al., S-nitrosylation regulates mitochondrial quality control via activation of parkin. Sci Rep, 2013. 3: p. 2202.
  32. Chung, K.K., et al., S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science, 2004. 304(5675): p. 1328-31.
  33. Um, J.W. and K.C. Chung, Functional modulation of parkin through physical interaction with SUMO-1. J Neurosci Res, 2006. 84(7): p. 1543-54.
  34. Corti, O., et al., The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet, 2003. 12(12): p. 1427-37.
  35. da Costa, C.A., et al., Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat Cell Biol, 2009. 11(11): p. 1370-5.
  36. Kubli, D.A., M.N. Quinsay, and A.B. Gustafsson, Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun Integr Biol, 2013. 6(4): p. e24511.
  37. Gong, G., et al., Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science, 2015. 350(6265): p. aad2459.
  38. Hamacher-Brady, A., N.R. Brady, and R.A. Gottlieb, Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem, 2006. 281(40): p. 29776-87.
  39. Huang, C., et al., Autophagy induced by ischemic preconditioning is essential for cardioprotection. J Cardiovasc Transl Res, 2010. 3(4): p. 365-73.
  40. Huang, C., et al., Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS One, 2011. 6(6): p. e20975.
  41. Feng, Y., et al., WDR26 promotes mitophagy of cardiomyocytes induced by hypoxia through Parkin translocation. Acta Biochim Biophys Sin (Shanghai), 2016. 48(12): p. 1075-1084.
  42. Labazi, H. and A.J. Trask, Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome. Pharmacol Res, 2017. 123: p. 114-121.
  43. Sun, L., et al., Overexpression of Rcan1-1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy. Mol Cells, 2014. 37(11): p. 785-94.
  44. Tang, Y., J. Liu, and J. Long, Phosphatase and tensin homolog-induced putative kinase 1 and Parkin in diabetic heart: Role of mitophagy. J Diabetes Investig, 2015. 6(3): p. 250-5.
  45. Watanabe, M., et al., Activation of the ubiquitin-proteasome system against arsenic trioxide cardiotoxicity involves ubiquitin ligase Parkin for mitochondrial homeostasis. Toxicology, 2014. 322: p. 43-50.
  46. Abe, J., et al., Cardiac progenitor cells activated by mitochondrial delivery of resveratrol enhance the survival of a doxorubicin-induced cardiomyopathy mouse model via the mitochondrial activation of a damaged myocardium. Journal of Controlled Release Official Journal of the Controlled Release Society, 2017. 269: p. 177.
  47. Yin, J., et al., Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway. Toxicol In Vitro, 2018. 51: p. 1-10.

Cite this Article:

  • BibTex
  • RIS
  • APA
  • Harvard
  • IEEE
  • MLA
  • Vancouver
  • Chicago

International Journal of Sciences is Open Access Journal.
This article is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) License.
Author(s) retain the copyrights of this article, though, publication rights are with Alkhaer Publications.

Search Articles

Issue October 2019

Volume 8, October 2019


Table of Contents


Order Print Copy

World-wide Delivery is FREE

Share this Issue with Friends:


Submit your Paper